Bausch HealthBHC +5.81%58 Market Cap is $1,965 Mil as of Jun. 26, 2026. GuruFocus rates BHC with a GF Score™ of 58/100 and a GF Value™ of $7.91 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,023 Drug Manufacturers companies, Bausch Health ranks better than 85.24% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bausch Health's share price for the quarter that ended in Mar. 2026 was $5.4. Bausch Health's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 373 Mil. Therefore, Bausch Health's market cap for the quarter that ended in Mar. 2026 was $2,017 Mil.
Bausch Health's quarterly market cap
increased
from Sep. 2025 ($2,390 Mil) to Dec. 2025 ($2,575 Mil) but then
declined
from Dec. 2025 ($2,575 Mil) to Mar. 2026 ($2,017 Mil).
Bausch Health's annual market cap
increased
from Dec. 2023 ($2,929 Mil) to Dec. 2024 ($2,965 Mil) but then
declined
from Dec. 2024 ($2,965 Mil) to Dec. 2025 ($2,575 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bausch Health's Enterprise Value for Today is $22,430 Mil.
Bausch Health (NYSE:BHC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bausch Health Market Cap Related Terms
Bausch Health Market Cap Historical Data
* Premium members only.
The historical data trend for Bausch Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch Health Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Bausch Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bausch Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch Health (BHC) has a Market Cap of $1,965 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bausch Health and its competitors. According to the industry distribution chart, Bausch Health ranks #151 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 14.8%.
Is Bausch Health's Market Cap too high?
Bausch Health's current Market Cap is $1,965 Mil. The Drug Manufacturers industry median Market Cap is 205.37. Bausch Health's value of $1,965 Mil is 856.8% above this industry median. Based on the distribution chart, Bausch Health ranks #151 out of 1023 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Bausch Health has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bausch Health ranks #151 out of 1023 companies for Market Cap. This places Bausch Health in the top 15% of its industry — outperforming the majority of peers. The industry median Market Cap is 205.37. Bausch Health's value of $1,965 Mil is 856.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bausch Health's current Market Cap of $1,965 Mil is 856.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bausch Health and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bausch Health's current Market Cap is $1,965 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (BHC) is currently considered Possible Value Trap. The stock's GF Value™ is $7.91, compared to a current price of $5.28 — trading 33.2% below its estimated fair value. The current Market Cap is $1,965 Mil and 856.8% above the Drug Manufacturers industry median of 205.37. Bausch Health's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bausch Health (BHC), the current Market Cap is $1,965 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bausch Health (BHC) Overvalued in 2026?
Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued.
The current stock price of $5.28 is trading 33.2% below its estimated GF Value™ of $7.91.
GuruFocus considers Bausch Health to be Possible Value Trap.
Key valuation signals for BHC:
Market Cap: $1,965 Mil
GF Value™: $7.91 vs. price of $5.28 (33.2% below fair value)
Industry Position: 856.8% above the Drug Manufacturers median (#151 of 1023)
No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
58GF Score
Get the complete analysis for BHC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHC has been successfully added to your 
